SKINCATCH Trial: Skin cancer and tumor health care

Completed

• Conditions: 10040900; basal cell carcinoma; skin cancer; skin malignancies

• Registration Number: NL-OMON42459
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 600

Inclusion Criteria

patient presenting with a skin tumor at the general practitioner

Exclusion Criteria

age under 18
critically ill (ASA classification 3,4,5,6)
unable to understand patient information material without an interpreter or help

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary outcomes<br /><br><br /><br>1. therapeutic: proportion of histological complete excisions of BCCs by GPs:<br /><br>low risk BCCs, i.e. smaller than 1 cm, not on high-risk locations on the body,<br /><br>superficial spreading or nodular histological subtype; compared to the<br /><br>proportion of the histological complete excisions of these same type of BCCs by<br /><br>dermatologists in the care-as-usual arm.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcome<br /><br>Diagnostic: positive predictive value of the diagnosis of the skin tumor by the<br /><br>GP in the intervention arm compared to the GP in the care-as-usual arm.<br /><br>Cost-effectiveness analysis of the direct costs of the intervention.<br /><br>Patient preferences and patient satisfaction.</p><br>